Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

74.33
Delayed Data
As of Feb 05
 -0.73 / -0.97%
Today’s Change
73.97
Today|||52-Week Range
106.84
-13.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Operating ActivitiesNet Income / Starting Line1.9B2.3B1.9B1.8B
 
 
 
 
 
Depreciation853.7M1.3B1.5B1.4B
 
 
 
 
 
Total Other Cash Flow-38.9M338.6M446.4M57.2M
 
 
 
 
 
Funds From Operations2.7B3.9B3.9B3.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-2.3B2.2B936.2M110.1M
 
 
 
 
 
Net Cash Flow - Operating Activities5.1B1.7B2.9B3.2B
 
 
 
 
 
 
InvestingIncrease In Investments-403.3M0.00-110.0M-36.7M
 
 
 
 
Decrease In Investments3.8B4.9M-4.9M0.00
 
 
 
 
Capital Expenditures-801.3M-460.3M-574.6M-587.0M
 
 
 
 
 
Fixed Asset Disposal-332.3M0.000.000.00
 
 
Net Assets From Acquisitions -327.2M-15.7B-420.8M-310.0M
 
 
 
 
 
Other Investing - Uses715.0M-241.4M-480.5M-205.6M
 
 
 
 
 
Other Investing - Sources-2.8B10.0B-314.5M340.9M
 
 
 
 
 
Net Cash Flow Investing-927.5M-6.4B-1.9B-798.5M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.00----
Long Term Borrowings3.8B4.9B-1.9B-314.5M
 
 
 
 
 
Long Term Debt Reduction-2.6B0.000.000.00
 
 
Net Proceeds Stock Sale0.0080.5M-80.5M0.00
 
 
 
Common Preferred Redeemed-4.2B0.00-542.0M-1.9B
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total72.5M-6.5B-123.1M-33.3M
 
 
 
 
 
Other Sources - Financing2.4B0.000.000.00
 
 
Other Uses - Financing-1.5M188.4M-148.4M-6.8M
 
 
 
 
 
Net Cash Flow - Financing-654.6M-1.7B-2.5B-2.2B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-158.7M56.9M70.1M-66.7M
 
 
 
 
 
 
Net Change In Cash3.5B-6.5B-1.4B138.1M